75
Participants
Start Date
July 31, 2015
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2017
Florida Hospital Cancer Institute, Orlando
Lead Sponsor
OvaGene Oncology, Inc.
INDUSTRY